- Report
- July 2025
- 83 Pages
Global
From €3500EUR$4,155USD£3,147GBP
- Report
- January 2026
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- September 2025
- 145 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- May 2025
- 200 Pages
Europe
From €2247EUR$2,490USD£1,952GBP
- Report
- October 2023
- 157 Pages
Global
From €4196EUR$4,650USD£3,646GBP
- Report
- March 2025
- 100 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- December 2023
- 111 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- September 2023
- 180 Pages
Global
From €5370EUR$5,950USD£4,665GBP
- Report
- May 2024
- 200 Pages
Global
From €3745EUR$4,150USD£3,254GBP
- Report
- March 2022
- 300 Pages
Global
From €4512EUR$5,000USD£3,920GBP
- Report
- August 2024
- 150 Pages
Global
From €3384EUR$3,750USD£2,940GBP
- Report
- October 2024
- 207 Pages
Global
From €7174EUR$7,950USD£6,233GBP
- Report
- September 2022
- 112 Pages
Global
From €3565EUR$3,950USD£3,097GBP
- Report
- March 2025
- 180 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- February 2025
- 182 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- July 2024
- 110 Pages
Global
From €4287EUR$4,750USD£3,724GBP
- Report
- February 2024
- 120 Pages
Global
From €4287EUR$4,750USD£3,724GBP
- Report
- February 2024
- 90 Pages
United States
From €4287EUR$4,750USD£3,724GBP
- Report
- February 2024
- 130 Pages
Global
From €4287EUR$4,750USD£3,724GBP
- Report
- April 2023
- 115 Pages
Global
From €4287EUR$4,750USD£3,724GBP

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery.
Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage.
Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases.
Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more